November 29, 2014 12:47 AM ET

Biotechnology

Company Overview of Iris Molecular Diagnostics

Company Overview

Iris Molecular Diagnostics, a bio-technology company, operates as a molecular diagnostics company. It develops technology platforms diagnostic method immunoassay technology and bubble isolation technology that enables separation and concentration of rare cells in blood and urine. Iris Molecular Diagnostics was formerly known as Leucadia Technologies, Inc., is based in Carlsbad, California. As of 4/4/2006, Leucadia Technologies, Inc. is a subsidiary of IRIS International Inc..

2075 Corte Del Nogal

Carlsbad, CA 92009-1413

United States

Phone:

760-438-9923

Key Executives for Iris Molecular Diagnostics

Chairman and Chief Executive Officer
Age: 71
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Catalyst Biosciences, Inc. United States
MenoGeniX, Inc United States
BioPheresis Technologies, Inc. United States
Signalway Antibody Co.,Ltd United States
ImmunoNewco, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Iris Molecular Diagnostics, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.